Navigation Links
NeoTract Designates Dr. Timothy Lesser as UroLift® Center of Excellence
Date:7/18/2019

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Timothy Lesser, MD, Skyline Urology in Torrance, CA has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Lesser has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Lesser as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #
For Teleflex Incorporated:
Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations

Media:
Nicole Osmer, 650.454.0504
nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Read the full story at https://www.prweb.com/releases/neotract_designates_dr_timothy_lesser_as_urolift_center_of_excellence/prweb16449493.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. NeoTract Designates Dr. Kalpesh Patel as UroLift® Center of Excellence
2. NeoTract Designates Dr. Elizabeth Mobley as UroLift® Center of Excellence
3. FDA Designates MST-188 As An Orphan Drug For Treatment Of Acute Limb Ischemia
4. Caris Life Sciences Designates MedStar Health a Caris Center of Excellence
5. Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence
6. Caris Life Sciences Designates Fox Chase Cancer Center a Caris Center of Excellence in Precision Medicine
7. IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
8. Pharmavite Appoints Timothy Toll Chief Customer Officer
9. Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
10. HemoSonics Appoints Timothy Fischer President and Chief Executive Officer
11. Enable Injections Names Timothy R. Flaherty VP & CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2020)... FALLS CHURCH, Va. (PRWEB) , ... February 14, ... ... Imports, of Pharmaceuticals, Biologics and Medical Devices, An FDAnews Webinar , Tuesday, Feb. ... latest on importation issues with pharmaceuticals and medical devices? If one does not ...
(Date:2/13/2020)... WASHINGTON (PRWEB) , ... February 13, 2020 , ... Data ... provided by the National Institutes of Health (NIH) in 2019 had a significant economic ... the District of Columbia. UMR’s annual report, “ NIH’s Role in Sustaining the U.S. ...
(Date:2/11/2020)... , ... February 11, 2020 , ... Acuity Eye ... Eye Center run by Dr. Daniel Coden, Dr. Arthur Perry, and Dr. Steven Pratt ... have served patients in the La Jolla and San Diego community for over 40 ...
Breaking Medicine Technology:
(Date:2/16/2020)... ... February 16, 2020 , ... Accumen ... is partnering with AABB and The Joint Commission to provide a complimentary series ... teams (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. ...
(Date:2/14/2020)... ... February 14, 2020 , ... ScripHessco has announced the ... The guide breaks down the benefits of chiropractic care during pregnancy and how ... pregnancy is quite beneficial to the mother’s health. Seeing a chiropractor during pregnancy ...
(Date:2/13/2020)... ... , ... Charles Seal-Villafranca, DHA(c), MSHA, CDP, ALFM-BC, the Administrator ... his re-election as the President of the Arizona State Board of Examiners of ... President of the State Board, Villafranca acts as the chief judge to grant ...
(Date:2/11/2020)... ... 11, 2020 , ... Soterius, Inc., a global provider of ... a new, significantly larger business premises in Lawrenceville, NJ. The move supports the ... of digital technology platforms. , “As our customer base and offerings continue to ...
(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is now enrolling ... in Las Vegas. The training consists of thread lift placement on real patients for ... PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The procedures are ...
Breaking Medicine News(10 mins):